| Catalog | name | Description | price |
|---|---|---|---|
| R-R-2822 | Exendin-4 acetate CAS No.914454-01-6 | Exendin-4 acetate (Exenatide acetate)/CAS No.914454-01-6, a 39 amino acid peptide, is a long-acting glucagon-like peptide-1 receptor agonist with an IC50 of 3.22 nM. | price> |
| R-R-2823 | Retatrutide TFA | Retatrutide (LY3437943) TFA is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide TFA binds human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide TFA can be used for the research of obesity. | price> |
| R-R-2824 | LGD-6972 CAS No.1207989-09-0 | LGD-6972/CAS No.1207989-09-0 is a selective and orally active glucagon receptor antagonist. LGD-6972 has the potential for type 2 diabetes research. | price> |
| R-R-2825 | NNC-0640 CAS No.307986-98-7 | NNC-0640/CAS No.307986-98-7 is a potent human G-protein-coupled glucagon receptor (GCGR) negative allosteric modulator (NAM) with an IC50 of 69.2 nM. | price> |
| R-R-2826 | Lixisenatide acetate CAS No.1997361-87-1 | Lixisenatide acetate/CAS No.1997361-87-1 is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM). | price> |
| R-R-2827 | GLP-1 moiety from Dulaglutide CAS No.1197810-60-8 | GLP-1 moiety from Dulaglutide/CAS No.1197810-60-8 is a 31-amino acid fragment of Dulaglutide which is a glucagon-like peptide 1 receptor (GLP-1) agonist, extracted from patent US 20160369010 A1. | price> |
| R-R-2828 | GLP-1R agonist 2 CAS No.281209-71-0 | GLP-1R agonist 2 (compound 2)/CAS No.281209-71-0 is a potent GLP-1R agonist. GLP-1R agonist 2 has the potential for the research of metabolic diseases like Type2 Diabetes and Obesity. | price> |
| R-R-2829 | Survodutide CAS No.2805997-46-8 | Survodutide (BI 456906)/CAS No.2805997-46-8 is a potent, selective glucagon receptor/GLP-1 receptor (GCGR/GLP-1R) dual agonist with EC50s of 0.52 nM and 0.33 nM in CHO-K1 cells, respectively. Survodutide, a 29-amino-acid peptide, is a potent acylated peptide containing a C18 fatty acid. Survodutide has robust anti-obesity efficacy achieved by increasing energy expenditure and decreasing food intake. | price> |
| R-R-2830 | Glepaglutide acetate | Glepaglutide (ZP1848) acetate, a long-acting GLP-2 analogue, is a potent GLP-2R agonist. Glepaglutide acetate reduces faecal output and increases intestinal absorption. Glepaglutide acetate alleviates small intestinal inflammation. | price> |
| R-R-2831 | GLP-2(3-33) CAS No.275801-62-2 | GLP-2(3-33)/CAS No.275801-62-2, generated naturally by dipeptidylpeptidase IV (DPPIV), acts as a partial agonist on GLP-2 receptor (EC50=5.8 nM). | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


